OCUL Stock Analysis: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$9.88
-0.32 (-3.14%)
▼
5d:
+2.28%
30d:
+13.04%
90d:
+12.4%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Smart Money Distribution
None View Scanner →
Strength: 5.5/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OCUL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OCUL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: OCUL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $9.88, which is considered slightly high relative to its 30-day fair value range of $8.82 to $10.13.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $9.41, while resistance sits at $10.94. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: OCUL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.09 (+174.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $9.41, while resistance sits at $10.94. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: OCUL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.09 (+174.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.82 -
$10.13
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 174.2% below Wall St target ($27.09)
Trading Range Analysis
30-Day Trading Range
$8.82 -
$10.13
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.41
Resistance Level
$10.94
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.43
Wall Street Target
$27.09
(+174.2%)
Revenue Growth (YoY)
0.8%
Share & Embed Analysis
Last updated: July 14, 2026 12:34 AM ET
Data refreshes hourly during market hours. Next update: 1:34 AM
Data refreshes hourly during market hours. Next update: 1:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter Kaiser
SELL
2810 shares
2026-02-23
Pravin Dugel
SELL
20056 shares
2026-02-23
Sanjay Nayak
SELL
1759 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
